Skip to Main content Skip to Navigation
Journal articles

Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy

Thomas Gastinne 1 Amandine Le Bourgeois 1 Marianne Coste‐burel 1 Thierry Guillaume 1, 2 Pierre Peterlin 1 Alice Garnier 1 Berthe‐marie Imbert 1 Thomas Drumel 1 Beatrice Mahe 1 Viviane Dubruille 1 Nicolas Blin 1 Anne Lok 1 Cyrille Touzeau 1 Benoit Tessoulin 1 Maxime Jullien 1 Sophie Vanthygem 1 Marie C Béné 1 Philippe Moreau 1 Steven Le Gouill 1 Patrice Chevallier 1, 3 
1 CHU Nantes - Centre hospitalier universitaire de Nantes
2 CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
3 CRCINA-ÉQUIPE 1 - Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications
CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
Abstract : No abstract available
Keywords : BNT162b2 CAR-T cells COVID 19 SARS-CoV-2 mRNA vaccine
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-03388040
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Wednesday, October 20, 2021 - 10:50:46 AM
Last modification on : Wednesday, April 27, 2022 - 3:50:04 AM
Long-term archiving on: : Friday, January 21, 2022 - 7:28:28 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

INSERM | UNIV-NANTES | CNRS | UNIV-ANGERS | CRCINA

Citation

Thomas Gastinne, Amandine Le Bourgeois, Marianne Coste‐burel, Thierry Guillaume, Pierre Peterlin, et al.. Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy. British Journal of Haematology, Wiley, 2021, Online ahead of print. ⟨10.1111/bjh.17818⟩. ⟨inserm-03388040⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

22